Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arbutus Biopharma Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ABUS
Nasdaq
2836
www.arbutusbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arbutus Biopharma Corporation
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
- May 13th, 2026 5:30 am
The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals
- May 4th, 2026 12:49 am
Moderna’s Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway.
- May 1st, 2026 12:35 pm
Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales
- May 1st, 2026 9:32 am
Moderna Q1 2026 earnings beat on international COVID vaccine sales
- May 1st, 2026 7:05 am
Moderna sees revenue bump from international COVID vaccine sales
- May 1st, 2026 6:27 am
Arbutus Biopharma (ABUS): 10 Best Biotech Penny Stocks to Buy in 2026
- May 1st, 2026 3:22 am
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran
- Apr 23rd, 2026 1:29 am
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability
- Apr 17th, 2026 7:58 am
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
- Apr 15th, 2026 5:30 am
Arbutus: Q4 Earnings Snapshot
- Mar 23rd, 2026 5:39 am
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
- Mar 23rd, 2026 5:30 am
Moderna Settlement And EMA Opinion Reframe mRNA Platform Outlook
- Mar 7th, 2026 4:13 pm
Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears
- Mar 4th, 2026 6:00 pm
Does $2.25 Billion LNP Settlement And Global License Reshape The Bull Case For Moderna (MRNA)?
- Mar 4th, 2026 3:10 pm
Why Moderna (MRNA) Stock Is Trading Up Today
- Mar 4th, 2026 2:50 pm
These Stocks Are Today’s Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More
- Mar 4th, 2026 2:50 pm
US Equity Markets End Higher After Strong Services, Jobs Data
- Mar 4th, 2026 2:10 pm
Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement
- Mar 4th, 2026 2:02 pm
Update: Moderna Shares Rise After Company Enters Settlement Agreement with Arbutus Biopharma, Genevant Sciences
- Mar 4th, 2026 12:37 pm
Scroll